AnGes Inc
AnGes, Inc. engages in the research and development of gene-based medical products. It develops HGF gene therapy product for the treatment of ischemic diseases; NF-"B Decoy Oligo DNA for chronic discogenic lumber back pain; and DNA vaccines for the treatment of hypertension and cervical intraepithelial neoplasia, as well as intranasal formulation of the COVID-19 vaccine. The company was formerly … Read more
Market Cap & Net Worth: AnGes Inc (AMGXF)
AnGes Inc (OTCGREY:AMGXF) has a market capitalization of $139.07 Million ($139.07 Million) as of March 19, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #16907 globally and #6464 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AnGes Inc's stock price $0.36 by its total outstanding shares 386077320 (386.08 Million).
AnGes Inc Market Cap History: 2017 to 2025
AnGes Inc's market capitalization history from 2017 to 2025. Data shows change from $2.14 Billion to $139.07 Million (-29.88% CAGR).
AnGes Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AnGes Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
AnGes Inc's market cap is 0.25 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.14 Billion | $365.18 Million | -$3.76 Billion | 5.87x | N/A |
| 2018 | $2.14 Billion | $610.05 Million | -$3.00 Billion | 3.51x | N/A |
| 2019 | $2.14 Billion | $326.76 Million | -$3.75 Billion | 6.56x | N/A |
| 2020 | $4.48 Billion | $40.00 Million | -$4.21 Billion | 111.97x | N/A |
| 2021 | $1.25 Billion | $64.15 Million | -$13.68 Billion | 19.45x | N/A |
| 2022 | $432.41 Million | $65.53 Million | -$11.92 Billion | 6.60x | N/A |
| 2023 | $274.11 Million | $152.99 Million | -$7.44 Billion | 1.79x | N/A |
| 2024 | $157.79 Million | $643.64 Million | -$28.13 Billion | 0.25x | N/A |
Competitor Companies of AMGXF by Market Capitalization
Companies near AnGes Inc in the global market cap rankings as of March 19, 2026.
Key companies related to AnGes Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
AnGes Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, AnGes Inc's market cap moved from $2.14 Billion to $ 139.07 Million, with a yearly change of -29.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $139.07 Million | -11.87% |
| 2024 | $157.79 Million | -42.44% |
| 2023 | $274.11 Million | -36.61% |
| 2022 | $432.41 Million | -65.34% |
| 2021 | $1.25 Billion | -72.15% |
| 2020 | $4.48 Billion | +109.01% |
| 2019 | $2.14 Billion | 0.00% |
| 2018 | $2.14 Billion | 0.00% |
| 2017 | $2.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AnGes Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $139.07 Million USD |
| MoneyControl | $139.07 Million USD |
| MarketWatch | $139.07 Million USD |
| marketcap.company | $139.07 Million USD |
| Reuters | $139.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.